JP2012532191A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012532191A5 JP2012532191A5 JP2012519596A JP2012519596A JP2012532191A5 JP 2012532191 A5 JP2012532191 A5 JP 2012532191A5 JP 2012519596 A JP2012519596 A JP 2012519596A JP 2012519596 A JP2012519596 A JP 2012519596A JP 2012532191 A5 JP2012532191 A5 JP 2012532191A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- polymorph
- chronic
- mixture
- ethylenediamine salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- PIICEJLVQHRZGT-UHFFFAOYSA-N 1,2-ethanediamine Chemical class NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 5
- 206010006451 Bronchitis Diseases 0.000 claims 4
- 230000001684 chronic Effects 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 201000009890 sinusitis Diseases 0.000 claims 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 238000000634 powder X-ray diffraction Methods 0.000 claims 3
- 208000006673 Asthma Diseases 0.000 claims 2
- 206010006458 Bronchitis chronic Diseases 0.000 claims 2
- 208000007451 Chronic Bronchitis Diseases 0.000 claims 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 2
- 206010009137 Chronic sinusitis Diseases 0.000 claims 2
- 208000000592 Nasal Polyps Diseases 0.000 claims 2
- 102100007288 PTGDR2 Human genes 0.000 claims 2
- 101710013017 PTGDR2 Proteins 0.000 claims 2
- 206010039085 Rhinitis allergic Diseases 0.000 claims 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 2
- 230000001154 acute Effects 0.000 claims 2
- 201000010105 allergic rhinitis Diseases 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000002798 polar solvent Substances 0.000 claims 2
- 239000000843 powder Substances 0.000 claims 2
- 230000001376 precipitating Effects 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 239000003826 tablet Substances 0.000 claims 2
- MPVNLHUOKQVEEG-UHFFFAOYSA-N N-[4-[[4,6-bis(dimethylamino)pyrimidin-2-yl]methyl]phenyl]-4-(trifluoromethyl)benzamide Chemical compound CN(C)C1=CC(N(C)C)=NC(CC=2C=CC(NC(=O)C=3C=CC(=CC=3)C(F)(F)F)=CC=2)=N1 MPVNLHUOKQVEEG-UHFFFAOYSA-N 0.000 claims 1
- YKYONYBAUNKHLG-UHFFFAOYSA-N Propyl acetate Chemical compound CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000000443 aerosol Substances 0.000 claims 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M caproate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 239000006187 pill Substances 0.000 claims 1
- 239000003880 polar aprotic solvent Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 239000003380 propellant Substances 0.000 claims 1
- 229940090181 propyl acetate Drugs 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 239000006188 syrup Substances 0.000 claims 1
- 235000020357 syrup Nutrition 0.000 claims 1
Claims (14)
- 図1に示す粉末X線回折パターンと一致する粉末X線回折パターンを提供する、請求項1記載の多形体。
- 請求項1記載の前記多形体の治療上の有効量を含む医薬組成物。
- 錠剤、被覆錠剤、丸剤、顆粒剤又は粉末剤、シロップ剤、エマルジョン、懸濁液及び溶液から選択される経口投与に適した請求項3記載の医薬組成物。
- 注入投与に適した請求項3記載の医薬組成物。
- 吸入可能粉末、噴霧剤含有定量エアロゾル、噴霧剤を含まない吸入溶液から選択される、吸入投与に適した請求項3記載の医薬組成物。
- CRTH2活性に関連した疾病の治療のための請求項3〜6のいずれか1項記載の医薬組成物。
- 慢性気管支炎、慢性閉塞性気管支炎(COPD)、慢性副鼻腔炎、鼻ポリープ、アレルギー性鼻炎、慢性鼻副鼻腔炎、急性鼻副鼻腔炎及び喘息から選択される疾病を治療するための請求項3〜6のいずれか1項記載の医薬組成物。
- 前記工程(a)の混合物に種結晶を入れる工程を更に含む、請求項9又は10記載の方法。
- 前記極性の非プロトン性溶媒がアセトニトリル、酢酸エチル、酢酸プロピル及び酢酸n-ブチルから選択される、請求項9〜11のいずれか1項記載の方法。
- CRTH2活性に関連した疾病の治療のための医薬組成物を製造するための請求項1記載の多形体の使用。
- 慢性気管支炎、慢性閉塞性気管支炎(COPD)、慢性副鼻腔炎、鼻ポリープ、アレルギー性鼻炎、慢性鼻副鼻腔炎、急性鼻副鼻腔炎及び喘息から選択される疾病を治療するための医薬組成物を製造するための請求項1記載の多形体の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22316509P | 2009-07-06 | 2009-07-06 | |
US61/223,165 | 2009-07-06 | ||
PCT/US2010/040733 WO2011005645A1 (en) | 2009-07-06 | 2010-07-01 | Polymorph of [4,6-bis(dimethylamino)-2-(4-{[4-(trifluoromethyl)benzoyl]amino}benzyl)pyrimidin-5-yl] |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012532191A JP2012532191A (ja) | 2012-12-13 |
JP2012532191A5 true JP2012532191A5 (ja) | 2013-08-15 |
Family
ID=42352224
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012519596A Pending JP2012532191A (ja) | 2009-07-06 | 2010-07-01 | [4,6−ビス(ジメチルアミノ)−2−(4−{[4−(トリフルオロメチル)ベンゾイル]アミノ}ベンジル)ピリミジン−5−イル]の多形体 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20120142715A1 (ja) |
EP (1) | EP2451787B1 (ja) |
JP (1) | JP2012532191A (ja) |
WO (1) | WO2011005645A1 (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2008224844B2 (en) | 2007-03-14 | 2012-08-09 | Knopp Neurosciences, Inc. | Synthesis of chirally purified substituted benzothiazole diamines |
JP2012500283A (ja) | 2008-08-19 | 2012-01-05 | ノップ ニューロサイエンシーズ、インク. | (r)−プラミペキソールを使用した組成物並びにその方法 |
WO2013096816A1 (en) | 2011-12-22 | 2013-06-27 | Biogen Idec Ma Inc. | Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds |
US9662313B2 (en) | 2013-02-28 | 2017-05-30 | Knopp Biosciences Llc | Compositions and methods for treating amyotrophic lateral sclerosis in responders |
US9468630B2 (en) | 2013-07-12 | 2016-10-18 | Knopp Biosciences Llc | Compositions and methods for treating conditions related to increased eosinophils |
LT3019167T (lt) | 2013-07-12 | 2021-03-25 | Knopp Biosciences Llc | Eozinofilų ir (arba) bazofilų padidintų kiekių gydymas |
EP3038467B1 (en) | 2013-08-13 | 2020-07-29 | Knopp Biosciences LLC | Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders |
US9763918B2 (en) | 2013-08-13 | 2017-09-19 | Knopp Biosciences Llc | Compositions and methods for treating chronic urticaria |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4570630A (en) | 1983-08-03 | 1986-02-18 | Miles Laboratories, Inc. | Medicament inhalation device |
NO166268C (no) | 1985-07-30 | 1991-07-03 | Glaxo Group Ltd | Innretning for administrering av medikamenter til pasienter. |
SE453566B (sv) | 1986-03-07 | 1988-02-15 | Draco Ab | Anordning vid pulverinhalatorer |
SG45171A1 (en) | 1990-03-21 | 1998-01-16 | Boehringer Ingelheim Int | Atomising devices and methods |
DE4318455A1 (de) | 1993-06-03 | 1994-12-08 | Boehringer Ingelheim Kg | Kapselhalterung |
DE19536902A1 (de) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
EP2051943A4 (en) | 2006-08-03 | 2011-03-23 | Bromine Compounds Ltd | METHOD, DEVICE AND SYSTEM FOR WATER TREATMENT |
CN102898380A (zh) * | 2007-06-21 | 2013-01-30 | 艾克提麦斯医药品有限公司 | 一种crth2 拮抗剂的胺盐 |
CN101778830B (zh) | 2007-06-21 | 2013-03-20 | 艾克提麦斯医药品有限公司 | Crth2拮抗剂的微粒 |
-
2010
- 2010-07-01 WO PCT/US2010/040733 patent/WO2011005645A1/en active Application Filing
- 2010-07-01 JP JP2012519596A patent/JP2012532191A/ja active Pending
- 2010-07-01 US US13/382,366 patent/US20120142715A1/en not_active Abandoned
- 2010-07-01 EP EP10729777.2A patent/EP2451787B1/en not_active Not-in-force
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2012532191A5 (ja) | ||
JP4585610B2 (ja) | 治療用化合物のトシル酸塩およびその医薬組成物 | |
TWI526442B (zh) | 新的具有β2腎上腺素增效劑及M3毒蕈碱拮抗劑之活性的環己胺衍生物 | |
JP6364429B2 (ja) | β2アドレナリン受容体アゴニスト活性およびM3ムスカリン受容体アンタゴニスト活性の両方を有する、2−アミノ−1−ヒドロキシエチル−8−ヒドロキシキノリン−2(1H)−オン誘導体の塩 | |
JP2020535218A (ja) | SHP2のオクタヒドロシクロペンタ[c]ピロールのアロステリック阻害剤 | |
TWI401251B (zh) | 新穎化合物 | |
TWI586378B (zh) | 新穎醫藥調配物 | |
JP2011162556A5 (ja) | ||
CN104854105A (zh) | 具有毒蕈碱受体拮抗剂和β2肾上腺素能受体激动剂活性的化合物 | |
TW200424171A (en) | Indole derivatives useful for the treatment of diseases | |
JP2015503610A5 (ja) | ||
JP2016527220A5 (ja) | ||
JP2016525533A (ja) | ムスカリン受容体アンタゴニスト活性およびβ2アドレナリン受容体アゴニスト活性の両方を有する、2−アミノ−1−ヒドロキシエチル−8−ヒドロキシキノリン−2(1H)−オン誘導体の塩 | |
TW201319062A (zh) | 具有β2腎上腺素增效劑及M3毒蕈□拮抗劑之作用之新環己胺衍生物 | |
JP2013541592A5 (ja) | ||
JP2012533550A5 (ja) | ||
US10005771B2 (en) | Bicyclic derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities | |
WO2011098746A1 (en) | Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone | |
JP2018529657A5 (ja) | ||
HK1144433A1 (en) | Guanidine-containing compounds useful as muscarinic receptor antagonists | |
TW201217338A (en) | Crystalline oxalate salts of a diamide compound | |
JP2013538857A5 (ja) | ||
RU2014100744A (ru) | Лечение респираторных нарушений с помощью trpa1 антагонистов | |
JP2016506946A (ja) | 吸入療法用の多成分結晶粒子 | |
JP2010539154A (ja) | ムスカリン様受容体アンタゴニストとして活性な新規化合物 |